Received Sep 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 4T93R | — |
vaccine administration after a temperature excursion given that three vaccines involved in the excursion; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a 56-year-old male patient who received HAV (Havrix) (batch number 4T93R, expiry date 11-JUL-2026) for prophylaxis. On 03-JUL-2025, the patient received Havrix. On 03-JUL-2025, an unknown time after receiving Havrix, the patient experienced incorrect storage of drug (Verbatim: vaccine administration after a temperature excursion given that three vaccines involved in the excursion). The outcome of the incorrect storage of drug was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date:29-AUG-2025 This case is linked with US2025111571 reported by same reporter.; Sender's Comments: US-GSK-US2025111571:same reporter, different patient